Relmada Therapeutics, Inc. ( RLMD) - Stock Earnings
RLMD Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -10.1 million USD | — USD |
| 2025Q4 | -19.9 million USD | — USD |
| 2026Q1 | -19.1 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
RLMD Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -98.8 million USD | — USD |
| 2024 | -80.0 million USD | — USD |
| 2025 | -57.4 million USD | — USD |
| 2026 Est. | — | — |
RLMD
Price: $6.50
52 week price:
Earnings Per Share: -1.09 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 144200
Market Capitalization: 462.7 million